| Retinal Vein Occlusion |
ACTRN12611000300976: Bevacizumab intravitreal injection in the treatment of patients with Central Retinal Vein Occlusion. |
|
|
| Recruiting | 2 | 22 | | | Royal Adelaide Hospital, Royal Adelaide Hospital | Central retinal vein occlusion (CRVO) | | | | |
2012-000165-20: Clinical trial to evaluate the results of intravitreal bevacizumab injections in cases of recurrence of macular edema secondary to retinal vein thrombosis previously treated with ozurdex Ensayo Clínico para evaluar los resultados del tratamiento con inyecciones intravítreas de bevacizumab en los casos de recidiva del edema macular secundario a trombosis de vena de retina que ha sido tratado previamente con ozurdex |
|
|
| Ongoing | 2 | 53 | Europe | Solution for infusion, AVASTIN | Fundación para la Investigación biomédica del Hospital Universitario Ramón y Cajal. Madrid, Concedida ayuda a la investigación clínica independiente 2011.MSPI. EC11-136 | Macular edema secondary to retinal vein occlusion Edema macular secundario a oclusiones venosas de retina, Visual loss due to Macular edema after retinal vein occlusion La pérdida de visión por edema macular debido a trombosis venosa de la retina, Diseases [C] - Eye Diseases [C11] | | | | |
2008-006265-93: A prospective, randomized, masked and controlled trial of intravitreal bevacizumab (Avastin®) for central retinal vein occlusion (CRVO). |
|
|
| Ongoing | 2 | 60 | Europe | Avastin®, Avastin ®, Avastin ® | St Eriks Eye Hospital | Central retinal vein occlusion (CRVO) is a sight-threatening ocular condition without efficient treatment. | | | | |
2012-005439-10: Re-treatment with intravitreal application of ranibizumab guided by morphological macular changes documented by optical coherence tomography (OCT) in patients with macular edema due to branch retinal vein occlusion Wiederbehandlung mit Ranibizumab bei Patienten mit Makulaödem infolge eines Venenastverschlusses nach morphologischen Netzhautveränderungen erhoben mittels optischer Kohärenztomographie (OCT) |
|
|
| Ongoing | 2 | 24 | Europe | Ranibizumab, Lucentis (Ranibizumab), Lucentis (Ranibizumab) | University of Leipzig Ritterstr. 26, 04109 Leipzig, Novartis | macular edema secondary to branch retinal vein occlusion (BRVO) Makulaödem bei Venenastverschluss | | | | |
2005-003288-21: INTRAOCULAR BEVACIZUMAB (AVASTIN™) FOR CENTRAL AND BRANCH RETINAL VEIN OCCLUSION STUDY |
|
|
| Ongoing | 2 | 30 | Europe | Avastin, EU/1/04/300/001-002, AVASTIN, AVASTIN | Dept. of Ophthalmology, Medical University of Vienna | CENTRAL AND BRANCH RETINAL VEIN OCCLUSION | | | | |
2017-001143-12: A Pilot Study for the Evaluation of Minocycline in the Treatment of Central Retinal Vein Occlusions |
|
|
| Not yet recruiting | 2 | 20 | Europe | Minocycline, Capsule, Minocycline | The National Eye Institute, The National Eye Institute | Central Retinal Vein Occlusion, Central Retinal Vein Occlusion, Diseases [C] - Eye Diseases [C11] | | | | |
2017-001179-21: A Pilot Study for the Evaluation of Minocycline in the Treatment of Branch Retinal Vein Occlusions |
|
|
| Not yet recruiting | 2 | 20 | Europe | Minocycline, Capsule, Minocycline | The National Eye Institute, The National Eye Institute | Branch Retinal Vein Occlusion, Branch Retinal Vein Occlusion, Diseases [C] - Eye Diseases [C11] | | | | |
ChiCTR-IIR-17013018: A Multicenter, Randomized, Double blinding, Parallel Group, Placebo-controlled, Phase IIa Trial to explore the Dose-ranging and Evaluate the Efficacy and Safety of Xuesaitong Soft Capsules in the Treatment of Nonischemic Retinal Vein Occlusion with Static Blood Blocking Collaterals TCM zhen |
|
|
| Recruiting | 2 | 108 | | Xuesaitong Soft Capsules ;Xuesaitong Soft Capsules and Xuesaitong Soft Capsules simulants ;Xuesaitong Soft Capsules simulants (placebo) | Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine; Kunming Shenghuo Pharmaceutical Group Co., Ltd., raise independently | Nonischemic Retinal Vein Occlusion (Syndrome of Static Blood Blocking Collaterals) | | | | |
NCT04667910: 601 Versus Ranibizumab in Patients With Central Retinal Vein Occlusion (CRVO) |
|
|
| Not yet recruiting | 2 | 60 | RoW | 601 1.25mg, Drug 601, Ranibizuman 0.5 mg, Lucentis | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | Central Retinal Vein Occlusion | 07/22 | 01/23 | | |
NCT04667897: 601 Versus Ranibizumab in Patients With Branch Retinal Vein Occlusion (BRVO) |
|
|
| Not yet recruiting | 2 | 60 | RoW | 601 1.25mg, Drug 601, Ranibizuman 0.5 mg, Lucentis | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | Branch Retinal Vein Occlusion | 07/22 | 01/23 | | |
NCT05290948: Comparison of Combined Intravitreal Bevacizumab and Oral Acetazolamide Versus Intravitreal Bevacizumab Alone for the Treatment of Macular Edema Secondary to Retinal Vein Occlusions |
|
|
| Active, not recruiting | 2 | 57 | RoW | intravitreal injection of bevacizumab with acetazolamide tablets, intravitreal injection of bevacizumab | Shahid Beheshti University of Medical Sciences | Macular Edema | 07/22 | 12/22 | | |
NCT05532735: Safety and Proof of Concept Study of ANXV (Annexin A5) in Patients With Retinal Vein Occlusion |
|
|
| Active, not recruiting | 2 | 16 | US | ANXV | Annexin Pharmaceuticals AB, InFocus Clinical Research | Retinal Vein Occlusion | 07/24 | 07/24 | | |
NCT06176963: A Study to Evaluate the Usability of the SB11 PFS in Subjects With Wet AMD or Macular Oedema Secondary to RVO |
|
|
| Completed | 2 | 34 | Europe | SB11 PFS, Ranibizumab | Samsung Bioepis Co., Ltd. | Neovascular Age-related Macular Degeneration, Macular Edema, Retinal Vein Occlusion | 11/23 | 12/23 | | |
NCT04576689: Safety and Efficacy of IBE-814 Intravitreal (IVT) Implant - A Sustained, Low Dose Dexamethasone Therapy |
|
|
| Completed | 2 | 60 | Canada, RoW | IBE-814 70ug, Low dose, IBE-814 140ug, High dose | Ripple Therapeutics Pty Ltd, Novotech (Australia) Pty Limited | Diabetic Macular Oedema, Retinal Vein Occlusion With Macular Oedema | 04/23 | 03/24 | | |
| Completed | 1/2 | 16 | US | Autologous Bone Marrow CD34+ Stem Cells, Sham Therapy | The Emmes Company, LLC, National Eye Institute (NEI), University of California, Davis | Central Retinal Vein Occlusion | 12/23 | 02/24 | | |
